Literature DB >> 10048968

Epidemiology of adult medulloblastoma.

M T Giordana1, P Schiffer, M Lanotte, P Girardi, A Chio.   

Abstract

Medulloblastoma is one of the most common primary tumors of the central nervous system seen in children; in contrast, it is somewhat uncommon in adult age. Due to the infrequent occurrence, data on incidence rates are sparse. The present study was aimed at ascertaining the epidemiological characteristics of medulloblastoma in adult age in Piedmont during the period 1976-1995. Piedmont is a region in northwest Italy, which had a total population of 4.30 millions/year for the period mentioned. From the files of clinical records of patients hospitalized in neurologic and neurosurgical departments, 45 cases (32 males, 13 females) of histologically verified medulloblastoma were recorded. The incidence rate (annual per million) in the whole period studied was 0.5 (95% confidence interval, 0.36-0.67). The incidence rate was high in the age group 15 to 19 years (2.33/million/year) and decreased up to age 40, consistent with the embryonal origin of the tumor. No time-trend of incidence rate was found. Male excess was evident in all age groups and in each time period. Median survival time was 17.6 years; the 5-year survival rate was 69.9%. Survival rate in the present group of adult medulloblastoma is slightly better than that reported in clinical series. A comparison was made with incidence data concerning pediatric medulloblastoma reported in the Registry of Childhood Cancer of Piedmont: from 1980 to 1989, adult medulloblastomas represented 34% of medulloblastomas. The figure is higher than that generally assumed, and indicates that the occurrence of this embryonal tumor in adult age is relevant. Our epidemiological data are consistent with an embryonal origin of medulloblastoma.

Entities:  

Mesh:

Year:  1999        PMID: 10048968     DOI: 10.1002/(sici)1097-0215(19990301)80:5<689::aid-ijc10>3.0.co;2-g

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.

Authors:  Ulrich Herrlinger; A Steinbrecher; J Rieger; P Hau; R-D Kortmann; R Meyermann; M Schabet; M Bamberg; J Dichgans; U Bogdahn; M Weller
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

2.  Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Authors:  Paul L Moots; Anne O'Neill; Harold Londer; Minesh Mehta; Deborah T Blumenthal; Geoffrey R Barger; Margaret L Grunnet; Stuart Grossman; Mark R Gilbert; David Schiff
Journal:  Am J Clin Oncol       Date:  2018-06       Impact factor: 2.339

Review 3.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

4.  Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program.

Authors:  Michela Buglione; Paolo Ghirardelli; Luca Triggiani; Sara Pedretti; Nadia Pasinetti; Berardino De Bari; Sandro Tonoli; Paolo Borghetti; Luigi Spiazzi; Stefano Maria Magrini
Journal:  Rep Pract Oncol Radiother       Date:  2015-04-08

Review 5.  The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature.

Authors:  M Balducci; S Chiesa; D Chieffo; S Manfrida; N Dinapoli; A Fiorentino; F Miccichè; V Frascino; C Anile; V Valentini; B De Bari
Journal:  J Neurooncol       Date:  2011-07-31       Impact factor: 4.130

6.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

Authors:  David W Ellison; James Dalton; Mehmet Kocak; Sarah Leigh Nicholson; Charles Fraga; Geoff Neale; Anna M Kenney; Dan J Brat; Arie Perry; William H Yong; Roger E Taylor; Simon Bailey; Steven C Clifford; Richard J Gilbertson
Journal:  Acta Neuropathol       Date:  2011-01-26       Impact factor: 17.088

Review 7.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

8.  Adult medulloblastoma: clinical characters, prognostic factors, outcomes and patterns of relapse.

Authors:  Na Zhang; Taohui Ouyang; Huicong Kang; Wang Long; Benjamin Thomas; Suiqiang Zhu
Journal:  J Neurooncol       Date:  2015-05-31       Impact factor: 4.130

9.  Survivin expression in medulloblastoma: a possible marker for survival.

Authors:  Azza Abdel-Aziz; Mie Ali Ali Mohamed; Fatma Mohamed Farouk Akl; Ahmed Nageeb M Taha
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

Review 10.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.